Nkarta Inc. (NKTX) is scheduled to report updated clinical data from its ongoing clinical trial of NKX019, its CD19-directed CAR NK cell therapy candidate, today, December 5.
The company is developing allogeneic engineered natural killer (NK) cell therapies to treat cancer.
For comments and feedback contact: editorial@rttnews.com
Business News
April 24, 2026 15:15 ET Economics news flow was relatively light this week even as the conflict in the Middle East continued, raising concerns for policymakers. In the U.S., spending data, initial jobless claims and pending home sales were the highlights. Business confidence in the biggest euro area economy was in focus in Europe. Inflation data from Japan gained attention in Asia.